+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Infectious Diseases Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
Infectious Diseases Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)- Product Image
New

Infectious Diseases Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 261 Pages
  • June 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5916007
Description Jump to:
The global infectious diseases diagnostics market is witnessing significant growth, backed by technological innovations, growing demand for early detection, and rising prevalence of infectious diseases. According to the publisher, the market is projected to expand from US$ 40.32 billion in 2025 to US$ 57 billion by the end of 2032, registering a CAGR of 5.07% during the forecast period.

Market Insights

Infectious diseases remain a critical challenge across global healthcare systems, leading to an increasing reliance on effective diagnostic methods for early detection and treatment. The market is evolving rapidly with the integration of advanced technologies, such as digital molecular diagnostics, FISH, qPCR, next-generation sequencing, and mass spectrometry.

Healthcare providers globally are transitioning from conventional laboratory testing to portable, point-of-care diagnostics that offer greater accessibility, rapid results, and integration with mobile health platforms. This shift is particularly crucial in resource-limited settings where traditional laboratory infrastructure may not be feasible.

Key Drivers

One of the primary drivers of this market growth is the increasing global incidence of infectious diseases. Rising cases of respiratory illnesses, sexually transmitted diseases, and hospital-acquired infections are escalating the demand for accurate and rapid diagnostic solutions. For instance, testing for COVID-19, respiratory syncytial virus (RSV), influenza, and other infections has surged due to increasing public awareness and healthcare preparedness.

Moreover, evidence-based medicine is shaping healthcare decision-making, urging physicians to rely on precise diagnostics before initiating treatment. This shift is further fueling the demand for diagnostic kits and reagents, especially in high-volume usage environments like hospitals and diagnostic laboratories.

Business Opportunity

The growing demand for affordable and reliable diagnostic kits represents a major opportunity for manufacturers. Many emerging economies are emphasizing innovation in diagnostic technology to manage healthcare costs and increase disease prevention efforts. For example, initiatives in India are promoting solutions to tackle infectious diseases through innovative healthcare models.

Digital molecular diagnostics and next-generation point-of-care tools are creating possibilities for healthcare systems to redesign service delivery by reducing dependence on centralized labs. This opens up lucrative opportunities for players to tap into remote and underserved regions with cost-effective and high-precision kits.

Regional Analysis

North America is a dominant player, largely driven by increasing healthcare investments, growing public awareness, and strong R&D capabilities. The United States, in particular, witnessed heightened demand during the COVID-19 pandemic and continues to invest heavily in advanced diagnostic tools.

Japan remains a promising market owing to its high disease awareness, robust healthcare infrastructure, and government-backed approvals for diagnostic kits. Similarly, China’s market is growing rapidly due to a dense network of domestic manufacturers and technological progress in multiplex testing and rapid diagnostics.

Canada is also experiencing notable growth, propelled by public health initiatives and increasing cases of viral outbreaks, which underscore the importance of early diagnosis and laboratory advancements.

Key Players

The competitive Analysis is marked by strategic collaborations, product launches, and innovation-led growth. Key market participants include:

  • Affymetrix, Inc.
  • Ambion, Inc.
  • Applera Corporation
  • Cenetron Diagnostics
  • Cepheid, Inc.
  • Chiron Corporation
  • Dharmacon, Inc.
  • Digene Corporation
  • Gen-Probe Incorporated
  • Innogenetics NV
  • Nanogen, Inc.
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Hologic, Inc.
  • QIAGEN
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific
  • Meridian Bioscience, Inc.
These companies are investing in research and development, scaling production, and expanding their product portfolios to address the growing global demand.

Market Segmentation

By Product:

  • Instruments
  • Biochips
  • Microfluidics Based POCT
  • DNA Microarrays
  • Mass Spectrometry
  • Real-time PCR
  • FISH
  • Sequencing
  • Capillary Electrophoresis
  • Next Generation Sequencing
  • Kits and Reagents
  • Kits
  • Primary Antibodies
  • Secondary Antibodies
  • Substrates
  • Buffers
  • Consumables

By Test Type:

  • Screening Test
  • Diagnostic Test

By Application:

  • Hospital-Acquired Infections
  • Sexually Transmitted Diseases (STDs)
  • Sepsis
  • Meningitis
  • Respiratory Infections
  • HPV
  • Gastrointestinal Tract Infections
  • Infections in Transplant Patients
  • Hepatitis B and C
  • Tuberculosis
  • Others

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Academic and Research Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Infectious Diseases Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Infectious Diseases Diagnostics Market Outlook, 2019-2032
3.1. Global Infectious Diseases Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Instrument
3.1.1.1.1. Biochips
3.1.1.1.2. Microfluidics Based POCT
3.1.1.1.3. DNA Microarrays
3.1.1.1.4. Mass Spectrometry
3.1.1.1.5. Real-time Polymerase Chain Reaction (qPCR)
3.1.1.1.6. Fluorescence in situ Hybridization (FISH)
3.1.1.1.7. Sequencing
3.1.1.2. Kits and reagents
3.1.1.2.1. Kits
3.1.1.2.2. Primary antibodies
3.1.1.2.3. Secondary antibodies
3.1.1.2.4. Substrates
3.1.1.2.5. Buffers
3.1.1.3. Consumables
3.2. Global Infectious Diseases Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Screening Test
3.2.1.2. Diagnostic Test
3.3. Global Infectious Diseases Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Hospital- Acquired Infections
3.3.1.2. Sexually Transmitted Disease (STD)
3.3.1.3. Sepsis
3.3.1.4. Meningitis
3.3.1.5. Respiratory Infections
3.3.1.6. HPV
3.3.1.7. Gastrointestinal Tract Infections
3.3.1.8. Infection in Transplant Patients
3.3.1.9. Hepatitis B and C
3.3.1.10. Tuberculosis
3.3.1.11. Others
3.4. Global Infectious Diseases Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Hospitals
3.4.1.2. Diagnostic Laboratories
3.4.1.3. Clinics
3.4.1.4. Academic and Research Institutes
3.4.1.5. Others
3.5. Global Infectious Diseases Diagnostics Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Infectious Diseases Diagnostics Market Outlook, 2019-2032
4.1. North America Infectious Diseases Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Instrument
4.1.1.1.1. Biochips
4.1.1.1.2. Microfluidics Based POCT
4.1.1.1.3. DNA Microarrays
4.1.1.1.4. Mass Spectrometry
4.1.1.1.5. Real-time Polymerase Chain Reaction (qPCR)
4.1.1.1.6. Fluorescence in situ Hybridization (FISH)
4.1.1.1.7. Sequencing
4.1.1.2. Kits and reagents
4.1.1.2.1. Kits
4.1.1.2.2. Primary antibodies
4.1.1.2.3. Secondary antibodies
4.1.1.2.4. Substrates
4.1.1.2.5. Buffers
4.1.1.3. Consumables
4.2. North America Infectious Diseases Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Screening Test
4.2.1.2. Diagnostic Test
4.3. North America Infectious Diseases Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Hospital- Acquired Infections
4.3.1.2. Sexually Transmitted Disease (STD)
4.3.1.3. Sepsis
4.3.1.4. Meningitis
4.3.1.5. Respiratory Infections
4.3.1.6. HPV
4.3.1.7. Gastrointestinal Tract Infections
4.3.1.8. Infection in Transplant Patients
4.3.1.9. Hepatitis B and C
4.3.1.10. Tuberculosis
4.3.1.11. Others
4.4. North America Infectious Diseases Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Diagnostic Laboratories
4.4.1.3. Clinics
4.4.1.4. Academic and Research Institutes
4.4.1.5. Others
4.5. North America Infectious Diseases Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. U.S. Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
4.5.1.2. U.S. Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
4.5.1.3. U.S. Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
4.5.1.4. U.S. Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
4.5.1.5. Canada Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
4.5.1.6. Canada Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
4.5.1.7. Canada Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
4.5.1.8. Canada Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Infectious Diseases Diagnostics Market Outlook, 2019-2032
5.1. Europe Infectious Diseases Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Instrument
5.1.1.1.1. Biochips
5.1.1.1.2. Microfluidics Based POCT
5.1.1.1.3. DNA Microarrays
5.1.1.1.4. Mass Spectrometry
5.1.1.1.5. Real-time Polymerase Chain Reaction (qPCR)
5.1.1.1.6. Fluorescence in situ Hybridization (FISH)
5.1.1.1.7. Sequencing
5.1.1.2. Kits and reagents
5.1.1.2.1. Kits
5.1.1.2.2. Primary antibodies
5.1.1.2.3. Secondary antibodies
5.1.1.2.4. Substrates
5.1.1.2.5. Buffers
5.1.1.3. Consumables
5.2. Europe Infectious Diseases Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Screening Test
5.2.1.2. Diagnostic Test
5.3. Europe Infectious Diseases Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Hospital- Acquired Infections
5.3.1.2. Sexually Transmitted Disease (STD)
5.3.1.3. Sepsis
5.3.1.4. Meningitis
5.3.1.5. Respiratory Infections
5.3.1.6. HPV
5.3.1.7. Gastrointestinal Tract Infections
5.3.1.8. Infection in Transplant Patients
5.3.1.9. Hepatitis B and C
5.3.1.10. Tuberculosis
5.3.1.11. Others
5.4. Europe Infectious Diseases Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Diagnostic Laboratories
5.4.1.3. Clinics
5.4.1.4. Academic and Research Institutes
5.4.1.5. Others
5.5. Europe Infectious Diseases Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Germany Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
5.5.1.2. Germany Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
5.5.1.3. Germany Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
5.5.1.4. Germany Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
5.5.1.5. U.K. Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
5.5.1.6. U.K. Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
5.5.1.7. U.K. Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
5.5.1.8. U.K. Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
5.5.1.9. France Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
5.5.1.10. France Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
5.5.1.11. France Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
5.5.1.12. France Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
5.5.1.13. Italy Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
5.5.1.14. Italy Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
5.5.1.15. Italy Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
5.5.1.16. Italy Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
5.5.1.17. Turkey Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
5.5.1.18. Turkey Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
5.5.1.19. Turkey Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
5.5.1.20. Turkey Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
5.5.1.21. Russia Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
5.5.1.22. Russia Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
5.5.1.23. Russia Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
5.5.1.24. Russia Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
5.5.1.25. Rest of Europe Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
5.5.1.26. Rest of Europe Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
5.5.1.27. Rest of Europe Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
5.5.1.28. Rest of Europe Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Infectious Diseases Diagnostics Market Outlook, 2019-2032
6.1. Asia Pacific Infectious Diseases Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Instrument
6.1.1.1.1. Biochips
6.1.1.1.2. Microfluidics Based POCT
6.1.1.1.3. DNA Microarrays
6.1.1.1.4. Mass Spectrometry
6.1.1.1.5. Real-time Polymerase Chain Reaction (qPCR)
6.1.1.1.6. Fluorescence in situ Hybridization (FISH)
6.1.1.1.7. Sequencing
6.1.1.2. Kits and reagents
6.1.1.2.1. Kits
6.1.1.2.2. Primary antibodies
6.1.1.2.3. Secondary antibodies
6.1.1.2.4. Substrates
6.1.1.2.5. Buffers
6.1.1.3. Consumables
6.2. Asia Pacific Infectious Diseases Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Screening Test
6.2.1.2. Diagnostic Test
6.3. Asia Pacific Infectious Diseases Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Hospital- Acquired Infections
6.3.1.2. Sexually Transmitted Disease (STD)
6.3.1.3. Sepsis
6.3.1.4. Meningitis
6.3.1.5. Respiratory Infections
6.3.1.6. HPV
6.3.1.7. Gastrointestinal Tract Infections
6.3.1.8. Infection in Transplant Patients
6.3.1.9. Hepatitis B and C
6.3.1.10. Tuberculosis
6.3.1.11. Others
6.4. Asia Pacific Infectious Diseases Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Diagnostic Laboratories
6.4.1.3. Clinics
6.4.1.4. Academic and Research Institutes
6.4.1.5. Others
6.5. Asia Pacific Infectious Diseases Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. China Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
6.5.1.2. China Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
6.5.1.3. China Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
6.5.1.4. China Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
6.5.1.5. Japan Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
6.5.1.6. Japan Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
6.5.1.7. Japan Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
6.5.1.8. Japan Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
6.5.1.9. South Korea Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
6.5.1.10. South Korea Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
6.5.1.11. South Korea Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
6.5.1.12. South Korea Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
6.5.1.13. India Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
6.5.1.14. India Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
6.5.1.15. India Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
6.5.1.16. India Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
6.5.1.17. Southeast Asia Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
6.5.1.18. Southeast Asia Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
6.5.1.19. Southeast Asia Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
6.5.1.20. Southeast Asia Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
6.5.1.21. Rest of Asia Pacific Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
6.5.1.22. Rest of Asia Pacific Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
6.5.1.23. Rest of Asia Pacific Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
6.5.1.24. Rest of Asia Pacific Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Infectious Diseases Diagnostics Market Outlook, 2019-2032
7.1. Latin America Infectious Diseases Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Instrument
7.1.1.1.1. Biochips
7.1.1.1.2. Microfluidics Based POCT
7.1.1.1.3. DNA Microarrays
7.1.1.1.4. Mass Spectrometry
7.1.1.1.5. Real-time Polymerase Chain Reaction (qPCR)
7.1.1.1.6. Fluorescence in situ Hybridization (FISH)
7.1.1.1.7. Sequencing
7.1.1.2. Kits and reagents
7.1.1.2.1. Kits
7.1.1.2.2. Primary antibodies
7.1.1.2.3. Secondary antibodies
7.1.1.2.4. Substrates
7.1.1.2.5. Buffers
7.1.1.3. Consumables
7.2. Latin America Infectious Diseases Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2019-2032
7.2.1.1. Screening Test
7.2.1.2. Diagnostic Test
7.3. Latin America Infectious Diseases Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Hospital- Acquired Infections
7.3.1.2. Sexually Transmitted Disease (STD)
7.3.1.3. Sepsis
7.3.1.4. Meningitis
7.3.1.5. Respiratory Infections
7.3.1.6. HPV
7.3.1.7. Gastrointestinal Tract Infections
7.3.1.8. Infection in Transplant Patients
7.3.1.9. Hepatitis B and C
7.3.1.10. Tuberculosis
7.3.1.11. Others
7.4. Latin America Infectious Diseases Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Diagnostic Laboratories
7.4.1.3. Clinics
7.4.1.4. Academic and Research Institutes
7.4.1.5. Others
7.5. Latin America Infectious Diseases Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Brazil Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
7.5.1.2. Brazil Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
7.5.1.3. Brazil Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
7.5.1.4. Brazil Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
7.5.1.5. Mexico Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
7.5.1.6. Mexico Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
7.5.1.7. Mexico Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
7.5.1.8. Mexico Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
7.5.1.9. Argentina Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
7.5.1.10. Argentina Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
7.5.1.11. Argentina Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
7.5.1.12. Argentina Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
7.5.1.13. Rest of Latin America Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
7.5.1.14. Rest of Latin America Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
7.5.1.15. Rest of Latin America Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
7.5.1.16. Rest of Latin America Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Infectious Diseases Diagnostics Market Outlook, 2019-2032
8.1. Middle East & Africa Infectious Diseases Diagnostics Market Outlook, by Product, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Instrument
8.1.1.1.1. Biochips
8.1.1.1.2. Microfluidics Based POCT
8.1.1.1.3. DNA Microarrays
8.1.1.1.4. Mass Spectrometry
8.1.1.1.5. Real-time Polymerase Chain Reaction (qPCR)
8.1.1.1.6. Fluorescence in situ Hybridization (FISH)
8.1.1.1.7. Sequencing
8.1.1.2. Kits and reagents
8.1.1.2.1. Kits
8.1.1.2.2. Primary antibodies
8.1.1.2.3. Secondary antibodies
8.1.1.2.4. Substrates
8.1.1.2.5. Buffers
8.1.1.3. Consumables
8.2. Middle East & Africa Infectious Diseases Diagnostics Market Outlook, by Test Type, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. Screening Test
8.2.1.2. Diagnostic Test
8.3. Middle East & Africa Infectious Diseases Diagnostics Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Hospital- Acquired Infections
8.3.1.2. Sexually Transmitted Disease (STD)
8.3.1.3. Sepsis
8.3.1.4. Meningitis
8.3.1.5. Respiratory Infections
8.3.1.6. HPV
8.3.1.7. Gastrointestinal Tract Infections
8.3.1.8. Infection in Transplant Patients
8.3.1.9. Hepatitis B and C
8.3.1.10. Tuberculosis
8.3.1.11. Others
8.4. Middle East & Africa Infectious Diseases Diagnostics Market Outlook, by End User, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Diagnostic Laboratories
8.4.1.3. Clinics
8.4.1.4. Academic and Research Institutes
8.4.1.5. Others
8.5. Middle East & Africa Infectious Diseases Diagnostics Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. GCC Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
8.5.1.2. GCC Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
8.5.1.3. GCC Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
8.5.1.4. GCC Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
8.5.1.5. South Africa Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
8.5.1.6. South Africa Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
8.5.1.7. South Africa Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
8.5.1.8. South Africa Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
8.5.1.9. Egypt Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
8.5.1.10. Egypt Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
8.5.1.11. Egypt Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
8.5.1.12. Egypt Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
8.5.1.13. Nigeria Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
8.5.1.14. Nigeria Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
8.5.1.15. Nigeria Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
8.5.1.16. Nigeria Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
8.5.1.17. Rest of Middle East & Africa Infectious Diseases Diagnostics Market by Product, Value (US$ Bn), 2019-2032
8.5.1.18. Rest of Middle East & Africa Infectious Diseases Diagnostics Market by Test Type, Value (US$ Bn), 2019-2032
8.5.1.19. Rest of Middle East & Africa Infectious Diseases Diagnostics Market by Application, Value (US$ Bn), 2019-2032
8.5.1.20. Rest of Middle East & Africa Infectious Diseases Diagnostics Market by End User, Value (US$ Bn), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Application vs By Test Type Heatmap
9.2. Manufacturer vs By Test Type Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Affymetrix, Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Ambion, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Applera Corporation
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Cenetron Diagnostics
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Cepheid, Inc.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Chiron Corporation
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Dharmacon, Inc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Digene Corporation
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Gen-Probe Incorporated
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Innogenetics NV
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Affymetrix, Inc.
  • Ambion, Inc.
  • Applera Corporation
  • Cenetron Diagnostics
  • Cepheid, Inc.
  • Chiron Corporation
  • Dharmacon, Inc.
  • Digene Corporation
  • Gen-Probe Incorporated
  • Innogenetics NV
  • Nanogen, Inc.
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Hologic, Inc.,
  • QIAGEN
  • Myriad Genetics, Inc.,
  • Thermo Fisher Scientific
  • Meridian Bioscience, Inc.

Related Topics

Related Reports

Monkeypox (mpox) Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Monkeypox (mpox) Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 201 Pages
  • Global
From
Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Infectious Disease Diagnostic Market by Product, Sample Type, Technology, Testing Type, Disease Type, End-User - Global Forecast to 2030 - Product Image

Infectious Disease Diagnostic Market by Product, Sample Type, Technology, Testing Type, Disease Type, End-User - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Molecular Infectious Disease Testing Market by Product Type, Test Type, Technology, Application, End Users - Global Forecast to 2030 - Product Image

Molecular Infectious Disease Testing Market by Product Type, Test Type, Technology, Application, End Users - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Infectious Disease Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Infectious Disease Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.